BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $310M
1-Year Est. Return 6.98%
This Quarter Est. Return
1 Year Est. Return
+6.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$310M
AUM Growth
-$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1
+$10M
2
+$8.01M
3
+$5.98M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$3.28M
5
CMPS
Compass Pathways
CMPS
+$2.79M

Top Sells

1
+$44.5M
2
+$8.74M
3
+$3.07M
4
MREO
Mereo BioPharma
MREO
+$2.35M
5
GOCO icon
GoHealth
GOCO
+$1.61M

Sector Composition

1 Healthcare 44.2%
2 Financials 32.56%
3 Technology 12.36%
4 Consumer Discretionary 6.99%
5 Energy 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NCDL icon
1
Nuveen Churchill Direct Lending
NCDL
$703M
$68.6M 22.12%
4,039,553
OBDC icon
2
Blue Owl Capital
OBDC
$6.2B
$30M 9.67%
2,045,070
CGEM icon
3
Cullinan Oncology
CGEM
$425M
$18.4M 5.95%
2,435,972
+65,000
EVCM icon
4
EverCommerce
EVCM
$1.69B
$16.6M 5.34%
1,641,929
TRML
5
DELISTED
Tourmaline Bio
TRML
$15.8M 5.09%
1,037,107
-42,214
CNDT icon
6
Conduent
CNDT
$281M
$15.4M 4.96%
5,697,450
+71,991
ENGN icon
7
enGene Holdings
ENGN
$310M
$14.7M 4.74%
3,279,378
+119,403
HLLY icon
8
Holley
HLLY
$436M
$13.7M 4.41%
5,318,040
+2,327,746
LRMR icon
9
Larimar Therapeutics
LRMR
$296M
$10.3M 3.31%
4,778,040
+125,000
TQQQ icon
10
ProShares UltraPro QQQ
TQQQ
$28.6B
$10M 3.23%
+175,000
CVEO icon
11
Civeo
CVEO
$256M
$8.01M 2.58%
+348,226
IRON icon
12
Disc Medicine
IRON
$3.13B
$6.96M 2.25%
140,260
+20,000
ELDN icon
13
Eledon Pharmaceuticals
ELDN
$123M
$6.17M 1.99%
1,819,912
-140,000
CMPX icon
14
Compass Therapeutics
CMPX
$752M
$5.61M 1.81%
2,954,712
RARE icon
15
Ultragenyx Pharmaceutical
RARE
$2.96B
$5.55M 1.79%
153,238
+35,000
IMA
16
ImageneBio Inc
IMA
$92.7M
$5.24M 1.69%
340,927
CNTA
17
Centessa Pharmaceuticals
CNTA
$2.97B
$4.53M 1.46%
315,000
+95,000
CNTX icon
18
Context Therapeutics
CNTX
$103M
$4.51M 1.45%
7,367,906
+1,009,978
SGMT icon
19
Sagimet Biosciences
SGMT
$245M
$4.33M 1.4%
1,328,351
+4,474
EYPT icon
20
EyePoint Pharmaceuticals
EYPT
$926M
$4.32M 1.39%
797,594
+130,000
PLRX icon
21
Pliant Therapeutics
PLRX
$98.2M
$4.01M 1.29%
2,969,199
+200,000
PVLA
22
Palvella Therapeutics
PVLA
$861M
$3.93M 1.27%
140,259
-109,803
RPTX icon
23
Repare Therapeutics
RPTX
$72.6M
$3.4M 1.09%
3,443,659
ETWO
24
DELISTED
E2open Parent Holdings
ETWO
$3.3M 1.06%
1,650,943
MLYS icon
25
Mineralys Therapeutics
MLYS
$2.95B
$3.28M 1.06%
+206,296
1
2 3 4